Cargando…

Human health risk assessment of pharmaceuticals in the European Vecht River

Active pharmaceutical ingredients (APIs) can reach surface waters used for drinking water extraction and recreational activities, such as swimming and fishing. The aim of the present study was to systematically assess the lifetime human health risks posed by 15 individual APIs and their mixtures occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Daniel J., Oldenkamp, Rik, Ragas, Ad M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790459/
https://www.ncbi.nlm.nih.gov/pubmed/35112470
http://dx.doi.org/10.1002/ieam.4588
_version_ 1784859181852917760
author Duarte, Daniel J.
Oldenkamp, Rik
Ragas, Ad M. J.
author_facet Duarte, Daniel J.
Oldenkamp, Rik
Ragas, Ad M. J.
author_sort Duarte, Daniel J.
collection PubMed
description Active pharmaceutical ingredients (APIs) can reach surface waters used for drinking water extraction and recreational activities, such as swimming and fishing. The aim of the present study was to systematically assess the lifetime human health risks posed by 15 individual APIs and their mixtures occurring in the German–Dutch transboundary Vecht River. An exposure model was developed and used to assess the combined risks of oral and dermal exposure under a variety of exposure conditions. A total of 4500 API uptake values and 165 lifetime risk values were estimated for 15 and 11 APIs, respectively. Overall, the lifetime human health risks posed by the APIs and their mixtures based on modeling results were deemed acceptable under typical exposure conditions. Under very extreme environmental conditions and human behavior, API mixture risks were of potential concern while the risks of individual APIs were negligible, with a few exceptions. The antibiotic doxycycline and analgesic phenazone showed the highest and lowest risks, respectively. The study did not evaluate the potential risks caused by metabolite compounds. Recommendations for water managers are provided to help improve the accuracy and utility of human health risk assessments of pharmaceuticals. Integr Environ Assess Manag 2022;18:1639–1654. © 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
format Online
Article
Text
id pubmed-9790459
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97904592022-12-28 Human health risk assessment of pharmaceuticals in the European Vecht River Duarte, Daniel J. Oldenkamp, Rik Ragas, Ad M. J. Integr Environ Assess Manag Health & Ecological Risk Assessment Active pharmaceutical ingredients (APIs) can reach surface waters used for drinking water extraction and recreational activities, such as swimming and fishing. The aim of the present study was to systematically assess the lifetime human health risks posed by 15 individual APIs and their mixtures occurring in the German–Dutch transboundary Vecht River. An exposure model was developed and used to assess the combined risks of oral and dermal exposure under a variety of exposure conditions. A total of 4500 API uptake values and 165 lifetime risk values were estimated for 15 and 11 APIs, respectively. Overall, the lifetime human health risks posed by the APIs and their mixtures based on modeling results were deemed acceptable under typical exposure conditions. Under very extreme environmental conditions and human behavior, API mixture risks were of potential concern while the risks of individual APIs were negligible, with a few exceptions. The antibiotic doxycycline and analgesic phenazone showed the highest and lowest risks, respectively. The study did not evaluate the potential risks caused by metabolite compounds. Recommendations for water managers are provided to help improve the accuracy and utility of human health risk assessments of pharmaceuticals. Integr Environ Assess Manag 2022;18:1639–1654. © 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC). John Wiley and Sons Inc. 2022-02-28 2022-11 /pmc/articles/PMC9790459/ /pubmed/35112470 http://dx.doi.org/10.1002/ieam.4588 Text en © 2022 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC) https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Health & Ecological Risk Assessment
Duarte, Daniel J.
Oldenkamp, Rik
Ragas, Ad M. J.
Human health risk assessment of pharmaceuticals in the European Vecht River
title Human health risk assessment of pharmaceuticals in the European Vecht River
title_full Human health risk assessment of pharmaceuticals in the European Vecht River
title_fullStr Human health risk assessment of pharmaceuticals in the European Vecht River
title_full_unstemmed Human health risk assessment of pharmaceuticals in the European Vecht River
title_short Human health risk assessment of pharmaceuticals in the European Vecht River
title_sort human health risk assessment of pharmaceuticals in the european vecht river
topic Health & Ecological Risk Assessment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790459/
https://www.ncbi.nlm.nih.gov/pubmed/35112470
http://dx.doi.org/10.1002/ieam.4588
work_keys_str_mv AT duartedanielj humanhealthriskassessmentofpharmaceuticalsintheeuropeanvechtriver
AT oldenkamprik humanhealthriskassessmentofpharmaceuticalsintheeuropeanvechtriver
AT ragasadmj humanhealthriskassessmentofpharmaceuticalsintheeuropeanvechtriver